Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: Angiographic and intravascular ultrasound analysis from the TAXUS-V ISR Trial

Cardiovascular Revascularization Medicine

Volumn 11, Issue 3, 2010, Pages 140-148

  Koizumi, Tomomi ^a   Fitzgerald, Peter J ^a   Honda, Yasuhiro ^a   Ellis, Stephen G ^b   Kent, Kenneth ^c   Martin, Steven L ^d   Brown, Charles L ^e   Masud, A R Zaki ^f   Patterson, John B ^g   Greenberg, Joel ^h   Friedman, Mark ⁱ   Uchida, Takahiro ⁱ   Stone, Gregg W ^j  

^a STANFORD UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Washington Cardiology Center   (United States)

^d Nebraska Heart Institute   (United States)

^e PIEDMONT HOSPITAL   (United States)

^f BUFFALO GENERAL HOSPITAL   (United States)

^g FORSYTH MEDICAL CENTER   (United States)

^h Florida Heart Institute   (United States)

ⁱ BOSTON SCIENTIFIC CORPORATION   (United States)

^j NewYork Presbyterian Hospital   (United States)

more..

Author keywords

Drug eluting stent; High dose paclitaxel; In stent restenosis

Indexed keywords

PACLITAXEL; METAL;

ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BLOOD VESSEL DIAMETER; BRACHYTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; Q WAVE; RANDOMIZED CONTROLLED TRIAL; RIGHT CORONARY ARTERY; STENT THROMBOSIS; TREATMENT RESPONSE; AGED; ANALYSIS OF VARIANCE; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CORONARY RESTENOSIS; CORONARY STENOSIS; DEVICES; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; MIDDLE AGED; PHYSIOLOGY; PILOT STUDY; PROCEDURES; PROSPECTIVE STUDY; PROSTHESIS FAILURE; RADIOGRAPHY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STENT; SURVIVAL RATE; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VASCULAR PATENCY;

AGED; ANALYSIS OF VARIANCE; ANGIOPLASTY, BALLOON, CORONARY; BRACHYTHERAPY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METALS; MIDDLE AGED; PACLITAXEL; PILOT PROJECTS; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STENTS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR PATENCY;

EID: 77954261509     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2009.07.004     Document Type: Article

References (18)

1. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004, 350(3):221-231.
2. Weissman NJ, Koglin J, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, et al. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol 2005, 45(8):1201-1205.
3. Serruys PW, Foley DP, Suttorp MJ, Rensing BJ, Suryapranata H, Materne P, van den Bos A, Benit E, Anzuini A, Rutsch W, et al. A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. J Am Coll Cardiol 2002, 39(3):393-399.
4. Hoffmann R, Herrmann G, Silber S, Braun P, Werner GS, Hennen B, Rupprecht H, vom Dahl J, Hanrath P Randomized comparison of success and adverse event rates and cost effectiveness of one long versus two short stents for treatment of long coronary narrowings. Am J Cardiol 2002, 90(5):460-464.
5. Kobayashi Y, De Gregorio J, Kobayashi N, Akiyama T, Reimers B, Finci L, Di Mario C, Colombo A Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999, 34(3):651-659.
6. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005, 294(10):1215-1223.
7. Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, Airoldi F, Montorfano M, Michev I, Colombo A Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol 2005, 45(10):1570-1573.
8. Aoki J, Ong AT, Rodriguez Granillo GA, McFadden EP, van Mieghem CA, Valgimigli M, Tsuchida K, Sianos G, Regar E, de Jaegere PP, et al. "Full metal jacket" (stented length> or=64 mm) using drug-eluting stents for de novo coronary artery lesions. Am Heart J 2005, 150(5):994-999.
9. Degertekin M, Arampatzis CA, Lemos PA, Saia F, Hoye A, Daemen J, Tanabe K, Lee CH, Hofma SJ, Sianos G, et al. Very long sirolimus-eluting stent implantation for de novo coronary lesions. Am J Cardiol 2004, 93(7):826-829.
10. Aoki J, Mintz GS, Weissman NJ, Mann JT, Cannon L, Greenberg J, Grube E, Masud ARZ, Koglin J, Mandinov L, Stone GW Chronic arterial responses to overlapping paclitaxel-eluting stents. Insights from serial intravascular ultrasound analysis in the TAXUS-V and VI trials. J Am Coll Cardiol Intv. 2008, 1:161-167.
11. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 2006, 295(11):1253-1263.
12. Holmes DR, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, Kuntz RE, Fitzgerald PJ, Wang H, Caramanica E, et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA 2006, 295(11):1264-1273.
13. Wilson GJ, Polovick JE, Huibregtse BA, Poff BC Overlapping paclitaxel-eluting stents: Long-term effects in a porcine coronary artery model. Cardiovasc Res 2007, 76(2):361-372.
14. Kereiakes DJ, Wang H, Popma JJ, Kuntz RE, Donohoe DJ, Schofer J, Schampaert E, Meier B, Leon MB, Moses JW Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. J Am Coll Cardiol 2006, 48(1):21-31.
15. Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo LC, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2006, 67(4):595-599.
16. Lim VY, Buellesfeld L, Gerckens U, Mueller R, Schmidt T, Grube E Use of Taxus polymer-coated paclitaxel-eluting stents for treatment of in-stent restenosis in real world patients: results of clinical and angiographic follow-up at six months in a single-center registry. Catheter Cardiovasc Interv 2006, 68(3):343-348.
17. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007, 356(10):998-1008.
18. Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, van der Giessen WJ, Staberock M, de Feyter P, Muller R, Regar E, et al. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003, 107(4):559-564.